Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.

Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial. Int J Radiat Oncol Biol Phys. 2019 03 01; 103(3):686-696.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Angiotensin-Converting Enzyme Inhibitors
Chemoradiotherapy
Double-Blind Method
Dyspnea
Female
Humans
Lisinopril
Lung
Lung Neoplasms
Male
Middle Aged
Patient Safety
Pilot Projects
Placebos
Quality of Life
Radiation Injuries
Radiation Pneumonitis
Radiotherapy
Surveys and Questionnaires
Treatment Outcome

authors with profiles

James D Bearden